Self-Urinary Infection Testing Market is projected to reach US$ 18.86 billion by 2033

According to Future Market Insights, the Self-Urinary Infection Testing Market is expected to develop at a compounded annual growth rate (CAGR) of 7.8% between 2023 and 2033. The market is expected to be valued at US$ 8.9 billion in 2023. This figure is expected to climb to US$ 18.86 billion by 2033. Growth is likely to be fueled by an increase in the prevalence of simple Urinary tract infections and the resulting demand for self-testing kits, which are convenient and cost-effective.

UTIs are the most frequent bacterial infection in the world, accounting for about 25% of all infections in women and causing 250 million infections each year. Almost half of all women who get a UTI will have recurring infections that require extra antibiotic therapy. By the age of 24, one in every three women will require antibiotic treatment for UTIs. The main cause of this rise is an overuse of antibiotics in medicine and cattle.

Get a PDF Sample with Latest Market Insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13680

Advent of Telehealth and Virtual Care to Create Tailwind for the Self-Urinary Infection Testing Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth has gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Self-Urinary Infection Testing market.

Key Self-Urinary Infection Testing Market Takeaways and Projections

• The US is estimated to continue dominating the North America market, projecting fastest growth in the region through 2033.
• Germany Self-Urinary Infection Testing market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2023 to 2033.
• China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
• India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Avail Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-13680

Report Benefits & Key Questions Answered

• Self-Urinary Infection Testing Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Self-Urinary Infection Testing market. It also studies the impact of these dynamics on the market for the previous assessment period 2018 to 2022 to forecast the scope of market growth over the coming forecast period 2023 to 2033.
• Self-Urinary Infection Testing Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Self-Urinary Infection Testing market. As per the survey, Self-Urinary Infection Testing sales will project steady growth over the forecast period.
• Self-Urinary Infection Testing Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Self-Urinary Infection Testing market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
• Self-Urinary Infection Testing Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Self-Urinary Infection Testing market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Self-Urinary Infection Testing market.

Some of the prominent market players are profiled by FMI are:

• Cardinal Health.
• Abbott.
• Siemens Healthcare Private Limited
• F. Hoffmann-La Roche Ltd
• Beckman Coulter, Inc.
• Sysmex Middle East FZ-LLC
• Quidel Corporation.
• Bio-Rad Laboratories, Inc.
• ARKRAY, Inc.
• Others

Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-13680

Key Segments

By Product:

• Dipsticks
• Urine Assay Kit
• Creatinine Urine Diagnostic Test Kit
• Home Protein Urine Test Strips

By Application:

• Kidney Diseases
• Urinary Tract Infections
• Diabetes
• Other Diseases

By End User:

• Diagnostic Laboratories
• Hospitals & Clinics
• Home Care Settings
• Assisted Living Healthcare Facilities
• Research Laboratories & Institutes

Region

• North America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa